Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001284395 | SCV001470170 | likely pathogenic | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Not found in the total gnomAD dataset, and the data is high quality. |
Ambry Genetics | RCV002375326 | SCV002625525 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-01-08 | criteria provided, single submitter | clinical testing | The p.L1340* pathogenic mutation (also known as c.4019T>A), located in coding exon 9 of the BRCA1 gene, results from a T to A substitution at nucleotide position 4019. This changes the amino acid from a leucine to a stop codon within coding exon 9. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |